Substituted piperidines for the treatment of cancer
US11046681B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 9, 2017 |
| Grant date | Jun 29, 2021 |
| Priority date | — |
| Expiry date | Oct 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): wherein R1, R2, R3, n and W are as defined in the description. Medicinal products containing the same which are useful in treating conditions requiring pro-apoptotic and/or anti-proliferative agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.